LB2102
LB2102-1001
Phase 1 mab active
Quick answer
LB2102 for Small Cell Lung Cancer Extensive Stage is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Legend Biotech Corp
- Indication
- Small Cell Lung Cancer Extensive Stage
- Phase
- Phase 1
- Modality
- mab
- Status
- active